Mark A. Shifman

872 total citations
31 papers, 696 citations indexed

About

Mark A. Shifman is a scholar working on Molecular Biology, Spectroscopy and Hematology. According to data from OpenAlex, Mark A. Shifman has authored 31 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Spectroscopy and 4 papers in Hematology. Recurrent topics in Mark A. Shifman's work include Advanced Proteomics Techniques and Applications (6 papers), Mass Spectrometry Techniques and Applications (6 papers) and Biomedical Text Mining and Ontologies (4 papers). Mark A. Shifman is often cited by papers focused on Advanced Proteomics Techniques and Applications (6 papers), Mass Spectrometry Techniques and Applications (6 papers) and Biomedical Text Mining and Ontologies (4 papers). Mark A. Shifman collaborates with scholars based in United States and Canada. Mark A. Shifman's co-authors include Salvatore V. Pizzo, Perry L. Miller, Herbert E. Fuchs, Kenneth R. Williams, Kei‐Hoi Cheung, Christopher M. Colangelo, Nicholas Carriero, Robert Bjornson, Jesse Rinehart and James G. Lewis and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Analytical Chemistry.

In The Last Decade

Mark A. Shifman

30 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Shifman United States 13 325 231 115 103 71 31 696
Frank Vitzthum Germany 11 643 2.0× 96 0.4× 522 4.5× 78 0.8× 23 0.3× 24 1.1k
Ekaterina Gibiansky United States 19 361 1.1× 177 0.8× 24 0.2× 22 0.2× 123 1.7× 42 1.3k
Maceler Aldrovandi United Kingdom 13 486 1.5× 61 0.3× 38 0.3× 188 1.8× 12 0.2× 18 764
Jun Katada Japan 20 481 1.5× 51 0.2× 10 0.1× 74 0.7× 118 1.7× 36 1.3k
Shufen Cao United States 13 218 0.7× 51 0.2× 18 0.2× 52 0.5× 16 0.2× 43 503
Nicole Vivier France 9 181 0.6× 47 0.2× 13 0.1× 60 0.6× 30 0.4× 11 885
Yanli Song China 13 204 0.6× 23 0.1× 17 0.1× 55 0.5× 38 0.5× 41 579
Yuta Taniuchi Japan 14 218 0.7× 233 1.0× 6 0.1× 24 0.2× 58 0.8× 27 594
Els Brouwers Belgium 16 230 0.7× 186 0.8× 5 0.0× 145 1.4× 45 0.6× 35 1.0k
Sylvain Giraud Switzerland 14 155 0.5× 160 0.7× 36 0.3× 32 0.3× 12 0.2× 25 639

Countries citing papers authored by Mark A. Shifman

Since Specialization
Citations

This map shows the geographic impact of Mark A. Shifman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Shifman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Shifman more than expected).

Fields of papers citing papers by Mark A. Shifman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Shifman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Shifman. The network helps show where Mark A. Shifman may publish in the future.

Co-authorship network of co-authors of Mark A. Shifman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Shifman. A scholar is included among the top collaborators of Mark A. Shifman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Shifman. Mark A. Shifman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shifman, Mark A., Luis Marenco, Cynthia Brandt, et al.. (2017). A Clinical Decision Support System for Monitoring Post-Colonoscopy Patient Follow-Up and Scheduling.. PubMed. 2017. 295–301. 6 indexed citations
2.
Aerni, Hans R., Mark A. Shifman, Svetlana Rogulina, Patrick O’Donoghue, & Jesse Rinehart. (2014). Revealing the amino acid composition of proteins within an expanded genetic code. Nucleic Acids Research. 43(2). e8–e8. 67 indexed citations
3.
Colangelo, Christopher M., Gordana Ivosev, Lisa Chung, et al.. (2014). Development of a highly automated and multiplexed targeted proteome pipeline and assay for 112 rat brain synaptic proteins. PROTEOMICS. 15(7). 1202–1214. 15 indexed citations
4.
Bjornson, Robert, Nicholas Carriero, Christopher M. Colangelo, et al.. (2007). X!!Tandem, an Improved Method for Running X!Tandem in Parallel on Collections of Commodity Computers. Journal of Proteome Research. 7(1). 293–299. 109 indexed citations
5.
Bruce, Can, Mark A. Shifman, Perry L. Miller, & Erol E. Gulcicek. (2006). Probabilistic Enrichment of Phosphopeptides by Their Mass Defect. Analytical Chemistry. 78(13). 4374–4382. 24 indexed citations
6.
Shifman, Mark A., et al.. (2004). Approaches and Informatics Tools to Assist in the Integration of Similar Clinical Research Questionnaires. Methods of Information in Medicine. 43(2). 156–162. 12 indexed citations
7.
Shifman, Mark A.. (2004). Exploring the Portability of Informatics Capabilities from a Clinical Application to a Bioscience Application. Journal of the American Medical Informatics Association. 11(4). 294–299. 1 indexed citations
8.
Kannry, Joseph, Logan G. Wright, Mark A. Shifman, Samuel C. Silverstein, & Perry L. Miller. (1996). Portability Issues for a Structured Clinical Vocabulary: Mapping from Yale to the Columbia Medical Entities Dictionary. Journal of the American Medical Informatics Association. 3(1). 66–78. 20 indexed citations
9.
Reinitz, John, et al.. (1994). Computer-assisted restriction mapping: an integrated approach to handling experimental uncertainty. Computer applications in the biosciences. 10(4). 435–442. 7 indexed citations
10.
Shifman, Mark A., et al.. (1993). NetMenu: experience in the implementation of an institutional menu of information sources.. PubMed. 554–8. 6 indexed citations
11.
Shifman, Mark A., Andreas Windemuth, Klaus Schulten, & Perry L. Miller. (1992). Molecular dynamics simulation on a network of workstations using a machine-independent parallel programming language. Computers and Biomedical Research. 25(2). 168–180. 7 indexed citations
12.
Nadkarni, P., Stephen T. Reeders, Mark A. Shifman, & Perry L. Miller. (1992). CHROMINFO: a database for viewing and editing top-level chromosome data.. PubMed. 366–70.
13.
Pearce, John M., Mark A. Shifman, Alex A. Pappas, & Richard A. Komoroski. (1991). Analysis of phospholipids in human amniotic fluid by 31P NMR. Magnetic Resonance in Medicine. 21(1). 107–116. 24 indexed citations
14.
Shifman, Mark A.. (1991). FABHELP: A Rule-Based Consultation Program for FAB Classification of Acute Myeloid Leukemia and Myelodysplastic Syndromes. Laboratory Medicine. 22(9). 639–643. 2 indexed citations
15.
Shifman, Mark A., et al.. (1988). TREACT: An expert system consultation program to aid in the diagnosis of transfusion reactions. Transfusion. 28(3). 253–256. 1 indexed citations
16.
Simpson, Marcus B., et al.. (1988). Evaluation of a centrifugal blood cell processor for washing platelet concentrates. Transfusion. 28(1). 46–51. 19 indexed citations
17.
Shifman, Mark A., et al.. (1988). Prolog: a language for programming medical logic.. PubMed. 5(2). 36–40. 1 indexed citations
18.
Shifman, Mark A.. (1987). Expert Systems in the Clinical Laboratory. Laboratory Medicine. 18(4). 247–249. 2 indexed citations
19.
Stead, Nancy W., Kenneth A. Bauer, Thomas R. Kinney, et al.. (1983). Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor. The American Journal of Medicine. 74(1). 33–39. 77 indexed citations
20.
Shifman, Mark A., et al.. (1981). The neurotoxicity of 5-nonanone: Preliminary report. Toxicology Letters. 8(4-5). 283–288. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026